Dr Reddy’s Laboratories on Tuesday reported a 60% decline in consolidated net profit for the quarter ended September to ₹308.9 crore, against the same period last year. Total income from operations fell by 10% to ₹3616.3 crore during the period under review. The fall was due to lower sales amid increased competitive intensity in the US, the company stated. 